Pitched at London Tech Week on 9 June 2026, Lord Vallance's speech was less a celebration of British science than a warning that the UK still struggles at the scale-up stage. In the Department for Science, Innovation and Technology transcript, he argued that above-average growth will not happen without strong science and technology companies, and he put the job of turning research into larger domestic businesses near the centre of the government's plan. (gov.uk) For Market Pulse UK readers, that is the line worth keeping. Britain does not lack bright labs, university spin-outs or early-stage founders. The question is whether ministers can build a system that gives those firms customers, capital and enough policy certainty to stay in the UK once they begin to matter. (gov.uk)

The headline number was £86 billion of public R&D funding across the Spending Review period. Vallance broke that into £14.5 billion for curiosity-driven research, £8 billion for applied work tied to public priorities, £7 billion for innovative companies, £8 billion for skills and infrastructure, and at least £1 billion more for the Advanced Research and Invention Agency. The speech also pointed back to the digital and technologies sector plan, which centres policy on advanced connectivity, AI, cyber security, engineering biology, quantum and semiconductors. (gov.uk) That mix matters because it shows government trying to move beyond a grants-only mindset. The public case is that research money, growth capital, regulation and procurement should now work in sequence rather than as isolated schemes. It is a stronger story than Britain has often told in the past, although the harder part will be delivery across departments rather than another well-received speech from a conference stage. (gov.uk)

Quantum was presented as the clearest example of this approach. Vallance said the UK has spent more than a decade turning quantum from a research question into an engineering and company-building challenge, and he used London Tech Week to announce a new Quantum Growth Alliance with names including HSBC, Barclays, Standard Chartered, GSK, BP, Rolls-Royce, BAE Systems, BT, Vodafone and QinetiQ. The point is straightforward: government wants visible future buyers, not just more laboratory milestones. (gov.uk) That demand signal matters because ministers have already put real procurement money behind the sector. In March 2026, the government announced a quantum package worth up to £2 billion, including £1 billion for large-scale quantum computer procurement, while Vallance told the conference that £1.2 billion would be set aside in a future spending review to buy scaled machines. For investors and founders, that is the state saying the first serious customer may not be far away if UK firms can execute. (gov.uk)

Engineering biology was the second big growth theme. Vallance announced a £45 million Engineering Biology Value and Sharing Growth Fund to back the less glamorous but commercially necessary building blocks: DNA writing capacity, research automation, biomanufacturing and the use of biological data with AI models. He placed that on top of an existing £196 million research and innovation commitment and £184 million for scale-up infrastructure. (gov.uk) For businesses, this is the right diagnosis. Engineering biology rarely stalls because there is no science; it stalls because scaling production, proving quality and winning large customers takes time and capital. The government is now saying it understands that bottleneck. The fair question is whether procurement and private finance will follow quickly enough to stop promising firms being sold early or built elsewhere. (gov.uk)

On finance, the message was that Whitehall knows the UK is better at creating spin-outs than backing them through later rounds. Vallance said the British Business Bank now has £25.6 billion of permanent capacity and argued that pension reforms are beginning to push more institutional money towards growth assets. In parallel, the government launched its £500 million Sovereign AI fund in April 2026 to help home-grown AI firms start in Britain, scale faster and compete globally. (gov.uk) This is where the speech became most candid. Vallance's repeated line was not just 'start' but 'start, scale and stay'. That wording tells its own story: ministers are worried that British science keeps producing firms good enough to attract overseas buyers before the UK captures the jobs, tax base and supply-chain benefits that come with maturity. (gov.uk)

The other half of the case is regulation and public purchasing. Vallance pointed to the Regulatory Innovation Office and used the speech to flag a new MHRA sandbox, launched on 9 June 2026, to test whether AI can predict drug safety risks. The regulator says the scheme is designed to make medicines development safer and quicker while reducing reliance on animal testing. (gov.uk) Just as important was his emphasis on procurement. Government spends about £400 billion a year on contracts, according to both Vallance and recent Cabinet Office material. If even a modest share of that goes to innovative SMEs, it can do more for revenue credibility than another competition or innovation brochure. For smaller companies, an early public customer is often more valuable than a polished speech about ambition. (gov.uk)

What the speech got right is that Britain's problem in 2026 is no longer mainly invention. The UK still produces a disproportionately high share of research papers and highly cited work for its size, and the start-up pipeline is stronger than it was a decade ago. The gap sits between breakthrough science and industrial scale: manufacturing capacity, later-stage finance, procurement routes, adoption by large incumbents and the patience to keep companies here through the expensive middle years. (gov.uk) That is why this was a more serious business speech than the usual conference circuit offering. There was less interest in calling Britain brilliant and more interest in explaining how the state might act as investor, buyer and rule-setter at the same time. Still, readers should treat the package as a framework rather than a finished result. Contracts awarded, pension money committed and facilities built will tell the real story. (gov.uk)

For founders, the practical read-across is clear. Follow where procurement pathways are opening, especially in quantum, AI, health regulation and advanced manufacturing. For investors, watch whether pension capital and British Business Bank firepower actually reach later-stage rounds. For workers and students, the promise is that science policy is being tied more directly to jobs, skills and domestic supply chains rather than left as a research-only conversation. (gov.uk) The strongest line in Vallance's remarks was also the simplest: every day the UK fails to fix its scale-up problem is a missed opportunity. On 9 June 2026, London Tech Week heard a government that finally sounds aware of that risk. The next question is whether it can move quickly enough to keep the value of British science in Britain. (gov.uk)